Primary regulatory
Compounding and the FDA: Questions and Answers
FDA reference explaining the statutory distinction between compounded drugs and FDA-approved drugs.
U.S. Food and Drug AdministrationAccessed 2026-07-12
Registry record
Source metadata
- Publisher
- U.S. Food and Drug Administration
- Source type
- Primary regulatory
- Registry ID
fda-compounding-questions-answers
Source usage
Linked from 7 pages
Video audit
Injectable Peptides for Anti-Aging? A Dermatologist Explains GHK-Cu
Video auditPeptide BPC-157 - Does It Work? Breaking Down the Evidence and the Hype
Video auditAre Peptides Safe? What You Need to Know About BPC-157, TB-500 & Their Unknown Risks
Video auditPeptides: The Science, Uses & Safety | Dr. Abud Bakri
Video auditBenefits and Risks of Peptide Therapeutics for Physical and Mental Health
Video auditCan Peptides Heal Your Joints, Gut, and Brain? Doctors Explain the Evidence
Video auditPeptide Expert: What Do Peptides Actually Do?
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.